This is the protocol for a review and there is no abstract. The objectives are as follows:, To determine whether the use of calcium channel blockers for any cardiovascular indication (including hypertension, angina, myocardial infarction, left ventricular dysfunction, heart failure, arrhythmias) causes an increase in the incidence of heart failure when compared to placebo